QOP
BNTX icon

Quinn Opportunity Partners’s BioNTech BNTX Stock Holding History

Quinn Opportunity Partners’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.3M Sell
153,832
-75,000
-33% -$7.06M 0.66% 35
2026
Q1 		$20.3M Buy
228,832
+172,332
+305% +$17.7M 1.06% 20
2025
Q4 		$5.38M Buy
56,500
+33,500
+146% +$3.38M 0.23% 102
2025
Q3 		$2.27M Sell
23,000
-2,075
-8% -$222K 0.16% 131
2025
Q2 		$2.67M Sell
25,075
-172,871
-87% -$17.5M 0.22% 108
2025
Q1 		$18M Sell
197,946
-158,248
-44% -$17.7M 1.24% 17
2024
Q4 		$40.6M Sell
356,194
-48,306
-12% -$5.51M 2.74% 4
2024
Q3 		$48M Sell
404,500
-278,787
-41% -$25.6M 4.65% 2
2024
Q2 		$54.9M Sell
683,287
-30,096
-4% -$2.75M 6.24% 1
2024
Q1 		$65.8M Buy
713,383
+38,800
+6% +$3.72M 7.28% 1
2023
Q4 		$71.2M Buy
674,583
+15,200
+2% +$1.53M 7.4% 1
2023
Q3 		$71.6M Buy
659,383
+249,768
+61% +$27.6M 9.22% 1
2023
Q2 		$44.2M Buy
409,615
+61,650
+18% +$6.93M 6% 1
2023
Q1 		$43.3M Buy
347,965
+85,894
+33% +$11.8M 4.34% 2
2022
Q4 		$39.4M Sell
262,071
-7,986
-3% -$1.23M 4.82% 2
2022
Q3 		$36.4M Sell
270,057
-30,664
-10% -$4.69M 4.14% 3
2022
Q2 		$44.8M Sell
300,721
-101,518
-25% -$15.5M 3.9% 5
2022
Q1 		$68.6M Buy
402,239
+345,049
+603% +$58M 2.96% 10
2021
Q4 		$14.7M Buy
57,190
+55,190
+2,760% +$15.1M 0.9% 24
2021
Q3 		$546K Sell
2,000
-25,000
-93% -$7.95M 0.03% 192
2021
Q2 		$6.04M Sell
27,000
-51,460
-66% -$9.7M 0.38% 55
2021
Q1 		$8.57M Buy
78,460
+68,960
+726% +$7.32M 0.54% 42
2020
Q4 		$774K Buy
+9,500
New +$933K 0.07% 148

Other funds holding BNTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
GP
GSK plc London $602M AUM

Quinn Opportunity Partners's BNTX Position: Q2 2026 in Review

Quinn Opportunity Partners reduced its BioNTech (BNTX) stake by 33% in Q2 2026, selling an estimated $7.06M and leaving 153,832 shares worth $14.3M. The position accounts for 0.66% of the portfolio, ranked #35.

Quinn Opportunity Partners first reported a position in BNTX in Q4 2020 and has held it in 23 quarters since. The position peaked at $71.6M in Q3 2023. 282 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

  • Quinn Opportunity Partners held 153,832 shares of BioNTech worth $14.3M as of Q2 2026.
  • Quinn Opportunity Partners sold 75,000 BioNTech shares in Q2 2026, an estimated $7.06M.
  • BioNTech made up 0.66% of Quinn Opportunity Partners's portfolio in Q2 2026, its #35 holding.
  • Quinn Opportunity Partners first reported a position in BioNTech in Q4 2020 and has held it in 23 quarters since.
  • Quinn Opportunity Partners's BioNTech position peaked at $71.6M in Q3 2023.
  • 282 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Quinn Opportunity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.